| scholarly article | Q13442814 |
| P2093 | author name string | Gian Maria Rossolini | |
| Gianfranco Amicosante | |||
| Laura Pagani | |||
| Roberta Migliavacca | |||
| Lucia Pallecchi | |||
| Egidio Romero | |||
| Ernesto Giacobone | |||
| Cecilia Matti | |||
| P2860 | cites work | Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 |
| Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations | Q31876731 | ||
| A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae | Q33690561 | ||
| beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. | Q33693251 | ||
| Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases | Q33747422 | ||
| Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase | Q33972291 | ||
| A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil | Q33980082 | ||
| TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. | Q33980592 | ||
| New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates. | Q33981978 | ||
| New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis | Q35114864 | ||
| Potential virulence factors of Proteus bacilli. | Q36574211 | ||
| Partial amino acid sequence of penicillinase coded by Escherichia coli plasmid R6K | Q37592185 | ||
| Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322 | Q37592206 | ||
| Diversity of TEM mutants in Proteus mirabilis | Q39472171 | ||
| Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital | Q39474457 | ||
| Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. | Q39746711 | ||
| Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase | Q39781579 | ||
| PER-1 extended-spectrum beta-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy | Q50120564 | ||
| Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. | Q53337180 | ||
| Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. | Q53342280 | ||
| Extended-spectrum TEM- and SHV-type beta-lactamase-producing Klebsiella pneumoniae strains causing outbreaks in intensive care units in Italy. | Q54026754 | ||
| Extended-spectrum beta-lactamase in Proteus mirabilis. | Q54206520 | ||
| Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. | Q54380570 | ||
| Survey of the prevalence of beta-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital | Q67998624 | ||
| Outbreak of extended-spectrum beta-lactamase producing Serratia marcescens in an intensive care unit | Q72586702 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Proteus mirabilis | Q311273 |
| P304 | page(s) | 1549-1552 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Emerging extended-spectrum beta-lactamases in Proteus mirabilis | |
| P478 | volume | 40 |
| Q42689556 | ACT-6, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China |
| Q42112187 | Biochemical characterization of PER-2 and genetic environment of blaPER-2 |
| Q42071404 | CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy |
| Q42411062 | CTX-M1 ESBL-producing Klebsiella pneumoniae subsp. pneumoniae isolated from cases of bovine mastitis |
| Q48523920 | Characterization of an Outbreak of Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit in Italy |
| Q34108605 | Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate. |
| Q35968652 | Comparative Screening of Digestion Tract Toxic Genes in Proteus mirabilis |
| Q36676368 | Comparison of antibiotic resistance patterns in collections of Escherichia coli and Proteus mirabilis uropathogenic strains |
| Q38544980 | Detection of expanded-spectrum β-lactamases in Gram-negative bacteria in the 21st century |
| Q43168091 | Determination of a novel integron-located variant (blaOXA -320 ) of Class D β-lactamase in Proteus mirabilis |
| Q40062221 | Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy. |
| Q39739670 | Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia. |
| Q24534999 | Extended-spectrum beta-lactamases: a clinical update |
| Q34159849 | Extended-spectrum ß-lactamases in gram negative bacteria |
| Q61637557 | Extended-spectrum β-lactamase production in E. coli strains isolated from clinical bovine mastitis |
| Q37598717 | Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland |
| Q33770194 | Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria |
| Q33802564 | Genetic properties of blaCTX-M and blaPER β-lactamase genes in clinical isolates of Enterobacteriaceae by polymerase chain reaction |
| Q33520358 | Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii |
| Q34737402 | Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase |
| Q37809057 | Minor extended-spectrum β-lactamases. |
| Q36933326 | Molecular Epidemiology and Genetic Characteristics of Various blaPER Genes in Shanghai, China |
| Q58473979 | Molecular epidemiology and extended-spectrum β-lactamases production of Klebsiella pneumoniae isolated from three dairy herds |
| Q46735380 | Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital |
| Q41821207 | Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes |
| Q34782040 | Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy |
| Q35922116 | Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy |
| Q34188609 | Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains |
| Q34951483 | Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase |
| Q46460989 | Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002. |
| Q36098603 | Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex |
| Q35165008 | Overexpression of an outer membrane protein associated with decreased susceptibility to carbapenems in Proteus mirabilis |
| Q41901517 | PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii |
| Q35182631 | Persistence of antibiotic-resistant and -sensitive Proteus mirabilis strains in the digestive tract of the housefly (Musca domestica) and green bottle flies (Calliphoridae). |
| Q37657300 | Prevalence of Extended-Spectrum Beta-Lactamases-Producing Microorganisms in Patients Admitted at KRRH, Southwestern Uganda |
| Q34623275 | Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities |
| Q33236778 | Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase |
| Q45227667 | Pseudomonas aeruginosa isolates recovered from clinical and environmental samples in Buea, Cameroon: current status on biotyping and antibiogram |
| Q57602329 | Supercritical Carbon Dioxide as Non-Thermal Alternative Technology for Safe Handling of Clinical Wastes |
| Q40004048 | TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain |
| Q33634460 | The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea |
| Q33938238 | Tn5393d, a complex Tn5393 derivative carrying the PER-1 extended-spectrum beta-lactamase gene and other resistance determinants. |
| Q50134197 | Transposition of Tn1213 encoding the PER-1 Extended Spectrum β-lactamase |
Search more.